These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32825374)

  • 21. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
    Hindriksen S; Bramer AJ; Truong MA; Vromans MJM; Post JB; Verlaan-Klink I; Snippert HJ; Lens SMA; Hadders MA
    PLoS One; 2017; 12(6):e0179514. PubMed ID: 28640891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9 Assisted Multiplex Genome Editing Technique in Escherichia coli.
    Feng X; Zhao D; Zhang X; Ding X; Bi C
    Biotechnol J; 2018 Sep; 13(9):e1700604. PubMed ID: 29790644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9-Mediated Genome Editing in the Filamentous Ascomycete Huntiella omanensis.
    Wilson AM; Wingfield BD
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic gene editing in haematological disorders with CRISPR/Cas9.
    Jensen TI; Axelgaard E; Bak RO
    Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.
    Zhou Y; Liu Y; Hussmann D; Brøgger P; Al-Saaidi RA; Tan S; Lin L; Petersen TS; Zhou GQ; Bross P; Aagaard L; Klein T; Rønn SG; Pedersen HD; Bolund L; Nielsen AL; Sørensen CB; Luo Y
    Cell Mol Life Sci; 2016 Jul; 73(13):2543-63. PubMed ID: 26755436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
    Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
    Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
    Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 34. Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System.
    Aksoy YA; Yang B; Chen W; Hung T; Kuchel RP; Zammit NW; Grey ST; Goldys EM; Deng W
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52433-52444. PubMed ID: 33174413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CRISPR-Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis.
    Zhang L; Zhang H; Liu Y; Zhou J; Shen W; Liu L; Li Q; Chen X
    Biotechnol Bioeng; 2020 Feb; 117(2):531-542. PubMed ID: 31654413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RiboCas: A Universal CRISPR-Based Editing Tool for Clostridium.
    Cañadas IC; Groothuis D; Zygouropoulou M; Rodrigues R; Minton NP
    ACS Synth Biol; 2019 Jun; 8(6):1379-1390. PubMed ID: 31181894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Site-Specific Integration Reporter System That Enables Rapid Evaluation of CRISPR/Cas9-Mediated Genome Editing Strategies in CHO Cells.
    Hamaker NK; Lee KH
    Biotechnol J; 2020 Aug; 15(8):e2000057. PubMed ID: 32500600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized paired-sgRNA/Cas9 cloning and expression cassette triggers high-efficiency multiplex genome editing in kiwifruit.
    Wang Z; Wang S; Li D; Zhang Q; Li L; Zhong C; Liu Y; Huang H
    Plant Biotechnol J; 2018 Aug; 16(8):1424-1433. PubMed ID: 29331077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
    Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
    Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical transformation mediated CRISPR/Cas9 genome editing in Escherichia coli.
    Sun D; Wang L; Mao X; Fei M; Chen Y; Shen M; Qiu J
    Biotechnol Lett; 2019 Feb; 41(2):293-303. PubMed ID: 30547274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.